Tolimidone (MLR-1023) is an allosteric Lyn kinase activator that has been shown to reduce blood glucose levels in mice. Studies show that Tolimidone is an effective insulin receptor-potentiating agent that is potentially capable of producing durable blood glucose-lowering activity in diabetics. Tolimidone is a candidate for the treatment of type 2 diabetes.

CAS：41964-07-2
中文别名：5-(3-甲基苯酚基)-2-(1H)-嘧啶酮;
英文别名：QCR-285;Tolimidone (USAN);UNII-MU3JD8E9IS;5-(3-Methylphenoxy)- 2(1H)-pyrimidinone CP 26154;TOLIMIDONE;5-(m-Tolyloxy)-2-(1H)-pyrimidinon;Tolimidone [USAN:INN];5-m-tolyloxy-1H-pyrimidin-2-one;5-(3-methylphenoxy)-2(1H)-pyrimidinone;
分子式：C11H10N2O2
分子量：202.209
精确质量：202.074
Psa：54.98
Logp：1.8706

UNII：MU3JD8E9IS

密度：1.22g/cm3
熔点：163-164ºC
折射率：1.598

海关编码：2933599090
危险性描述：H319
信号词：Warning
危险标志：GHS07
危险性防范说明：P305 + P351 + P338